Zobrazeno 241 - 250
of 391
pro vyhledávání: ''
Autor:
Christine Böger, Sandra Krüger, Hans-Michael Behrens, Christoph Röcken, Micaela Mathiak, Holger Kalthoff
Publikováno v:
Oncotarget
Targeting the PD-1/PD-L1 immune checkpoint signaling is a novel promising treatment strategy in several tumor entities, and it is suggested that PD-L1/PD-1 expression is predictive for a PD-1/PD-L1 checkpoint inhibitor treatment response. We investig
Autor:
Yufeng Wang, Meng Xu, Tao Song, Zhikui Liu, Hongyong Zhang, Yuli Jia, Kangsheng Tu, Bowen Yao, Changwei Dou, Qing Li, Linglong Ding, Qingguang Liu
Publikováno v:
Oncotarget
Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. Accumulating studies have demonstrated that aberrant expression of several lncRNAs was found to be involved in the hepatocarcinogenesis. In this study, a lncRNA Ftx
Autor:
Baijun Dong, Shuangchun Ren, Song Wu, Yi Li, Ding Juan, Yong Tian, Guoqing Wang, Jihan Wang, Li Chong, Junfeng Hao, Heping Zhao, Xiaoxiao Zhu
Publikováno v:
Oncotarget
Renal cell carcinoma (RCC) is frequently diagnosed at advanced stages of disease, although early diagnosis has much favorable prognosis. This study assessed aberrant expression of cytosolic carboxypeptidase 6 (CCP6) leading to accumulation of serum p
Autor:
Xu-An Wang, Shanshan Xiang, Runfa Bao, Wenguang Wu, Maolan Li, Lin Jiang, Hao Weng, Yijun Shu, Huaifeng Li, Yang Cao, Haibin Liang, Yijian Zhang, Qian Dong, Fei Zhang, Yingbin Liu, Xiangsong Wu, Yuanyuan Ye, Yunping Hu
Publikováno v:
Oncotarget
Gallbladder cancer (GBC), the most common malignancy of the bile duct, is highly aggressive and has an extremely poor prognosis, which is a result of early metastasis. As it is regulated being at multiple levels, the metastatic cascade in GBC is comp
Autor:
Massimiliano Bonifacio, Martina Midolo, Michele Gottardi, Giulio Bassi, Armel Herve Nwabo Kamdje, Mariano Di Trapani, Omar Perbellini, Paul Takam Kamga, Alessandro Gatti, Achille Ambrosetti, Adriana Cassaro, Mauro Krampera, Federica Resci, Roberta Carusone
Publikováno v:
Oncotarget
// Paul Takam Kamga 1 , Giulio Bassi 1 , Adriana Cassaro 1 , Martina Midolo 1 , Mariano Di Trapani 1 , Alessandro Gatti 1 , Roberta Carusone 1 , Federica Resci 1 , Omar Perbellini 1 , Michele Gottardi 2 , Massimiliano Bonifacio 1 , Armel Herve Nwabo
Autor:
Eberhard Gunsilius, Andreas Pircher, Wolfgang Hilbe, Normann Steiner, Florian Kocher, Gerold Untergasser, Johann Kern, Renate Pichler, Ivo Graziadei, Christian Kremser, Nicolai Leonhartsberger, Karin Jöhrer, Isabel Heidegger
Publikováno v:
Oncotarget
Numerous antiangiogenic agents are approved for the treatment of oncological diseases. However, almost all patients develop evasive resistance mechanisms against antiangiogenic therapies. Currently no predictive biomarker for therapy resistance or re
Autor:
David Zurakowski, Pierre Vanden Borre, Eran Brauner, Viswanath Gunda, Salma Amin, Kate V. Dennett, Sareh Parangi, Yon Seon Kim, Gordon J. Freeman
Publikováno v:
Oncotarget
The interaction of programmed cell death-1 and its ligand is widely studied in cancer. Monoclonal antibodies blocking these molecules have had great success but little is known about them in thyroid cancer. We investigated the role of PD-L1 in thyroi
Autor:
Tomás Alarcón, Javier A. Menendez, Salvador Fernández-Arroyo, Jorge Joven, Núria Folguera-Blasco, Elisabet Cuyàs
Publikováno v:
RECERCAT (Dipòsit de la Recerca de Catalunya)
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Oncotarget
Recercat. Dipósit de la Recerca de Catalunya
instname
ResearcherID
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Oncotarget
Recercat. Dipósit de la Recerca de Catalunya
instname
ResearcherID
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
// Javier A. Menendez 1,2 , Nuria Folguera-Blasco 3 , Elisabet Cuyas 1,2 , Salvador Fernandez-Arroyo 4 , Jorge Joven 4 and Tomas Alarcon 3,5,6,7 1 ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute
Autor:
Erfei Chen, Jin Yang, Fangfang Yang, Lei Lei, Le Du, Ruitao Liu, Jing Dong, Hongjuan He, Meng Wang
Publikováno v:
Oncotarget
Ras-association domain family protein 6 (RASSF6) is a member of tumor suppressor RASSFs family with a wide range of function from RAS interaction, Hippo signaling involvement to cell cycle and apoptosis regulation. RASSF6 is reported inactivated in v
Autor:
Heidi Schwarzenbach, Fabian Trillsch, Klaus Pantel, Volkmar Müller, Xiaodan Meng, Karin Milde-Langosch
Publikováno v:
Oncotarget
Exosomes are membrane vesicles that mediate intercellular communication by transporting their molecular cargo from cell to cell. We investigated whether serum levels of exosomal miR-373, miR-200a, miR-200b and miR-200c and circulating exosomes have d